# Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.

> **NCT04641364** · PHASE1 · COMPLETED · sponsor: **The First Hospital of Jilin University** · enrollment: 80 (actual)

## Conditions studied

- Ascites

## Interventions

- **DRUG:** recombinant human albumin injection
- **DRUG:** Placebo
- **DRUG:** human albumin injection

## Key facts

- **NCT ID:** NCT04641364
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-24
- **Primary completion:** 2020-05-06
- **Final completion:** 2020-05-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04641364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04641364, "Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04641364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*